Basic Information
Basic information for LINC02223-210-36aa
Peptide Name LINC02223-210-36aa
Genome Position chr5:17852620-17852706,17873020-17873040[+]
Species Human
Peptide Sequence MEGVDPSFATGEDLLSKALSQESIQPCQQGALSFIV
Peptide Length 36
Unique No (LINC02223-203-36aa,LINC02223-206-36aa,LINC02223-208-36aa,LINC02223-209-36aa,LINC02223-211-36aa,LINC02223-214-36aa,LINC02223-216-36aa)
Grand Average of Hydropathicity 0.0972
Relative Molecular Mass 4427.8
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000249937;LINC02223
Transcript ID/Name ENST00000655908;LINC02223-210
Transcript Length 1167
Coding Ability 0.4542
DNA Sequence Corresponding to Peptide ATGGAGGGTGTAGATCCATCCTTTGCAACTGGTGAGGACCTCCTCAGTAAGGCACTGAGCCAGGAGTCTATACAGCCATGCCAGCAGGGAGCACTGTCTTTCATTGTC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :